Oryon Cell Therapies ("Oryon"), a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders, ...

How does mild hypoxia affect preterm babies? New research identifies a molecular mechanism that disrupts hippocampal communication without direct brain injury.

Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with ...

Oryon Cell Therapies (“Oryon”), a clinical-stage biotechnology company focused on developing autologous neuron replacement ...

An international research team from Bielefeld University and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP ...

Measuring neurofilament light chain levels 48 hours after cardiac arrest can predict long-term cognitive impairment, ...

Researchers are engineering a new class of miniature antibodies, called intrabodies, that can operate inside living cells to ...

New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked ...

Recent technological advances facilitate the reconstruction of complete brain connectomes in small organisms and partial ...

Aspen Neuroscience’s autologous, personalised stem cell therapy is set for a pivotal trial after it showed improved "ON" and ...

Every multicellular organism, from tiny worms to humans, elephants, and whales, needs a way for their cells to connect with ...

A newly identified role for the neuronal MPS shows it controls nutrient uptake by acting as a gatekeeper. Its disruption ...